e-learning
resources
Stockholm 2002
Monday 16.09.2002
Pulmonary hypertension
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Lung involvement distinct from pulmonary hypertension: a new feature of POEMS syndrome
J. M. Fellrath, R. Lemoine, J. D. Aubert (Lausanne, Switzerland)
Source:
Annual Congress 2002 - Pulmonary hypertension
Session:
Pulmonary hypertension
Session type:
Oral Presentation
Number:
2315
Disease area:
Interstitial lung diseases, Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. M. Fellrath, R. Lemoine, J. D. Aubert (Lausanne, Switzerland). Lung involvement distinct from pulmonary hypertension: a new feature of POEMS syndrome. Eur Respir J 2002; 20: Suppl. 38, 2315
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Efficacy of Breathox® device inhalation on acute symptoms associated with COVID-19 (BREATH study)
A 12-year-old male child with fever, productive cough and sudden onset paralysis
The definition of pulmonary hypertension: history, practical implications and current controversies
Related content which might interest you:
Pulmonary involvement in antisynthetase syndrome: more than myopathy
Source: Virtual Congress 2021 – What's new in respiratory problems in rare and systemic diseases
Year: 2021
Pulmonary hypertension in antisynthetase syndrome: prevalence, aetiology and survival
Source: Eur Respir J 2013; 42: 1271-1282
Year: 2013
Lung abnormalities in marfan syndrome: a pathogenetic model of early-onset emphysema?
Source: Annual Congress 2009 - Respiratory physiology
Year: 2009
Portopulmonary hypertension: a further clue to pathogenesis?
Source: Annual Congress 2005 - Challenges in the biological understanding of pulmonary arterial hypertension
Year: 2005
Pulmonary involvement in patients with Marfan syndrome
Source: Annual Congress 2012 - Pulmonary manifestations of systemic diseases
Year: 2012
Pulmonary involvement in Marfan syndrome
Source: International Congress 2018 – Management of chronic cough and respiratory muscle dysfunction
Year: 2018
Castleman disease variant of atypical POEMS syndrome: A case presentatIon
Source: International Congress 2014 – Clinical management of interstitial lung diseases and vasculitis
Year: 2014
Prolidase deficiency: a new genetic cause of combined pulmonary fibrosis and emphysema syndrome in the adult
Source: Eur Respir J, 55 (4) 1901952; 10.1183/13993003.01952-2019
Year: 2020
Early pulmonary phenotype in Hermansky-Pudlak syndrome: Analysis of the chILD-EU registry
Source: International Congress 2016 – Paediatric bronchology I
Year: 2016
Antisynthetase syndrome related interstitial lung disease may have a better treatment response than other forms of Idiopathic Inflammatory Myopathies: a multi-national study
Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020
The metabolic syndrome and pulmonary hypertension
Source: Virtual Congress 2020 – Pulmonary vascular diseases
Year: 2020
Nephrotic syndrome associated with pulmonary tuberculosis – case presentation
Source: Eur Respir J 2007; 30: Suppl. 51, 88s
Year: 2007
Idiopathic pulmonary fibrosis: multiple causes and multiple mechanisms?
Source: Eur Respir J 2007; 30: 835-839
Year: 2007
TBX4 syndrome: a systemic disease highlighted by pulmonary arterial hypertension in its most severe form
Source: Eur Respir J, 55 (5) 2000585; 10.1183/13993003.00585-2020
Year: 2020
Idiopathic pulmonary fibrosis phenotypes: Identification of new clinico-pathological stigmata
Source: Annual Congress 2010 - Clinical issues in idiopathic pulmonary fibrosis
Year: 2010
Combined pulmonary fibrosis and emphysema: A distinct entity?
Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis
Year: 2012
Pulmonary hypertension: a paradigm for rare pulmonary diseases
Source: Eur Respir Rev, 26 (146) 170120; 10.1183/16000617.0120-2017
Year: 2017
Chronic thromboembolic pulmonary hypertension: a distinct disease entity
Source: Eur Respir Rev 2015; 24: 246-252
Year: 2015
Prognostic significance of selected biomarkers in idiopathic pulmonary fibrosis, sarcoidosis, and chronic pulmonary obstructive disease
Source: International Congress 2014 – Sarcoidosis
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept